понедельник, 19 сентября 2016 г.

Holy Grail' of Oral Insulin Gives Way to Other Tablets at Novo

Holy Grail' of Oral Insulin Gives Way to Other Tablets at Novo


More than 30 years after diabetics began injecting themselves with the modern form of insulin, treatments in a pill seem as elusive as ever. Delivery of the hormone in a tablet is still considered the "holy grail," according to Mads Krogsgaard Thomsen, the chief science officer of Novo Nordisk A/S.



from Biotech News